Suppr超能文献

牛和猪腺病毒载体基因组在人源和非人类细胞系中的持久性。

Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.

机构信息

Department of Comparative Pathobiology, School of Veterinary Medicine, and Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907, USA.

出版信息

Virus Res. 2011 Nov;161(2):181-7. doi: 10.1016/j.virusres.2011.08.002. Epub 2011 Aug 16.

Abstract

The state of vector genome in transduced cells influences the duration of transgene expression and can be a safety concern if it gets integrated randomly into the host genome. Although human adenovirus (Ad) serotype 5 (HAd5) mainly persists in a linear episomal form, information regarding the state of bovine Ad serotype 3 (BAd3) and porcine Ad serotype 3 (PAd3) vector genomes in human and nonhuman cells is currently unknown. To address this issue, MDA-MB-231 (human), MDBK (bovine), PK-15 (porcine), MT1A2 (mouse) and NIH-3T3 (mouse) cell lines were infected with replication-defective BAd3, PAd3 or HAd5 vectors carrying the green fluorescent protein (GFP) gene. The persistence and the state of vector genome were assessed by quantitative real-time PCR and Southern blot hybridization, respectively. Levels of transgene and Ad gene expressions were quantified using real-time RT-PCR. Persistence of BAd3 or PAd3 vectors was comparable to that of HAd5 vector. Only the linear episomal form of the vector genome was observed with each vector. In addition, expression levels of transgene as well as viral genes by all three vectors were comparable and correlated with their transduction levels in each cell type. These results indicate comparable biologic behavior of BAd3, PAd3 and HAd5 vectors in cell culture.

摘要

转导细胞中的载体基因组状态会影响转基因的表达时间,如果它随机整合到宿主基因组中,可能会成为一个安全隐患。虽然人类腺病毒(Ad)血清型 5(HAd5)主要以线性附加体形式存在,但目前尚不清楚牛腺病毒(BAd3)和猪腺病毒(PAd3)载体基因组在人和非人类细胞中的状态。为了解决这个问题,用携带绿色荧光蛋白(GFP)基因的复制缺陷型 BAd3、PAd3 或 HAd5 载体感染 MDA-MB-231(人)、MDBK(牛)、PK-15(猪)、MT1A2(鼠)和 NIH-3T3(鼠)细胞系。分别通过定量实时 PCR 和 Southern 印迹杂交评估载体基因组的持续性和状态。使用实时 RT-PCR 定量转基因和 Ad 基因的表达。BAd3 或 PAd3 载体的持续性与 HAd5 载体相当。每种载体只观察到线性附加体形式的载体基因组。此外,三种载体的转基因表达水平以及病毒基因的表达水平均相当,并且与它们在每种细胞类型中的转导水平相关。这些结果表明 BAd3、PAd3 和 HAd5 载体在细胞培养中具有相似的生物学行为。

相似文献

1
Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.
Virus Res. 2011 Nov;161(2):181-7. doi: 10.1016/j.virusres.2011.08.002. Epub 2011 Aug 16.
7
Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.
Gene Ther. 2010 May;17(5):634-42. doi: 10.1038/gt.2010.1. Epub 2010 Feb 18.

引用本文的文献

1
Bovine Adenoviral Vector-Based Platform for Vaccine Development.
Vaccines (Basel). 2025 May 3;13(5):494. doi: 10.3390/vaccines13050494.
2
Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector.
Front Immunol. 2023 Nov 21;14:1305937. doi: 10.3389/fimmu.2023.1305937. eCollection 2023.
4
A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose.
Mol Ther Methods Clin Dev. 2018 Jul 17;10:210-222. doi: 10.1016/j.omtm.2018.07.007. eCollection 2018 Sep 21.
5
Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.
Hum Gene Ther. 2014 Apr;25(4):285-300. doi: 10.1089/hum.2013.228. Epub 2014 Mar 25.

本文引用的文献

1
Production of adenovirus vectors and their use as a delivery system for influenza vaccines.
Expert Opin Biol Ther. 2010 Oct;10(10):1469-87. doi: 10.1517/14712598.2010.519332.
2
Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.
Gene Ther. 2010 May;17(5):634-42. doi: 10.1038/gt.2010.1. Epub 2010 Feb 18.
3
Adenoviral vector-based strategies for cancer therapy.
Curr Drug ther. 2009 May 1;4(2):117-138. doi: 10.2174/157488509788185123.
5
Episomal vectors for gene therapy.
Curr Gene Ther. 2008 Jun;8(3):147-61. doi: 10.2174/156652308784746440.
6
New serotypes of adenoviral vectors.
Curr Opin Mol Ther. 2006 Oct;8(5):423-31.
7
Current strategies and future directions for eluding adenoviral vector immunity.
Curr Gene Ther. 2006 Apr;6(2):215-26. doi: 10.2174/156652306776359478.
8
Development of nonhuman adenoviruses as vaccine vectors.
Vaccine. 2006 Feb 13;24(7):849-62. doi: 10.1016/j.vaccine.2005.08.101. Epub 2005 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验